三阴性乳腺癌
结合
抗体
药品
癌症
转移性乳腺癌
医学
癌症研究
乳腺癌
跨膜蛋白
抗体-药物偶联物
受体
药理学
单克隆抗体
免疫学
内科学
数学分析
数学
作者
Madeline Gough,K. Kwah,Tanweer A. Khan,Yaozhen He,C. Pyke,G. Ratnayake,C. Snell,J. Hooper,T. Kryza
标识
DOI:10.1016/s0959-8049(22)01571-4
摘要
Background: CUB-domain containing- protein 1 (CDCP1) is a transmembrane receptor involved in the progression of several cancers. Recent studies demonstrate that CDCP1 is a rational target for the development of innovative targeted therapies for cancer including theranostics agents and antibody-drug conjugates.
科研通智能强力驱动
Strongly Powered by AbleSci AI